Rhythm Pharmaceuticals
RYTM
#3320
Rank
NZ$6.05 B
Marketcap
$98.52
Share price
3.33%
Change (1 day)
33.92%
Change (1 year)

Revenue for Rhythm Pharmaceuticals (RYTM)

Revenue in 2024 (TTM): NZ$0.18 Billion

According to Rhythm Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is NZ$0.19 Billion. In 2023 the company made a revenue of NZ$0.12 Billion an increase over the revenue in the year 2022 that were of NZ$37.23 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Rhythm Pharmaceuticals from 2017 to 2024

201820192020202120222023$50M$0.1B$0.15B$0.2B0companiesmarketcap.com

Annual revenue

Year Revenue Change
2024 (TTM) NZ$0.18 B48.6%
2023 NZ$0.12 B228.85%
2022 NZ$37.23 M706.29%
2021 NZ$4.61 M
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA